Patents Assigned to Noogen LLC
  • Modified oligonucleotides and methods for their synthesis
    Patent number: 12415828
    Abstract: Modified oligonucleotides that contain one or more of the phosphate groups substituted at phosphorus and methods for their synthesis are disclosed.
    Type: Grant
    Filed: September 4, 2020
    Date of Patent: September 16, 2025
    Assignee: NOOGEN LLC
    Inventors: Dmitry Stetsenko, Maxim Kupryushkin, Dmitrii Pyshnyi
  • Modified oligonucleotides and methods for their synthesis
    Patent number: 11208430
    Abstract: The present invention is directed to modified oligonucleotides having the following Formula (I) wherein one or more of phosphate groups are substituted at phosphorus, and methods for their synthesis. The modified oligonucleotides are useful for diagnostic applications involving sequence specific recognition of a nucleic acid and for use in a method of medical treatment.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: December 28, 2021
    Assignee: NOOGEN LLC
    Inventors: Dmitry Stetsenko, Maxim Kupryushkin, Dmitrii Pyshnyi
  • Modified oligonucleotides and methods for their synthesis
    Patent number: 10870674
    Abstract: The present invention is directed to modified oligonucleotides having the following Formula (I) wherein one or more of phosphate groups are substituted at phosphorus, and methods for their synthesis. The modified oligonucleotides are useful for diagnostic applications involving sequence specific recognition of a nucleic acid and for use in a method of medical treatment.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: December 22, 2020
    Assignee: Noogen LLC
    Inventors: Dmitry Stetsenko, Maxim Kupryushkin, Dmitrii Pyshnyi
  • Modified oligonucleotides and methods for their synthesis
    Patent number: 10766918
    Abstract: The present invention is directed to modified oligonucleotides having the following Formula (I) wherein one or more of phosphate groups are substituted at phosphorus, and methods for their synthesis. The modified oligonucleotides are useful for diagnostic applications involving sequence specific recognition of a nucleic acid and for use in a method of medical treatment.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: September 8, 2020
    Assignee: Noogen LLC
    Inventors: Dmitry Stetsenko, Maxim Kupryushkin, Dmitrii Pyshnyi